Skip to main content
Log in

Gehtests

Walk tests

  • Leitthema
  • Published:
Der Pneumologe Aims and scope

Zusammenfassung

Viele Patienten mit chronischer Herzinsuffizienz und chronischen respiratorischen Leiden sind durch die Krankheit in ihren Aktivitäten limitiert. Bei diesen Patienten können standardisierte Gehtests den funktionellen Status erfassen und zur Therapiekontrolle dienen. Der 6-min-Gehtest bei selbst gewählter Geschwindigkeit ist als verbreiteter, wenig komplexer Test geeignet, die funktionelle Kapazität auf submaximalem Level zu erfassen. Shuttle-Walk-Tests mit vorgegebener und sich steigernder Geschwindigkeit spiegeln die funktionelle Kapazität auf maximalem Level wider.

Abstract

Activity levels of many patients suffering from chronic cardiac insufficiency and chronic respiratory diseases are often limited. Standardized walk tests can be used to evaluate the functional status as well as monitoring therapy in these patients. The self-paced 6-min walk test is a widely used low complexity test to measure functional capacity on a submaximal level. Shuttle walk tests are controlled-pacing walk tests to evaluate functional capacity on maximal levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Notes

  1. Da der mit den Gehtests zu Untersuchende in den meisten Fällen krank ist, wird im Folgenden der Ausdruck „Patient“ auch als Synonym für „Proband“ verwendet.

Literatur

  1. ATS-Statement (2002) Guidelines for the six-minute walk-test. Am J Respir Crit Care Med 166:111–117

    Google Scholar 

  2. Bansal V, Hill K, Dolmage TE et al (2008) Modifying track layout from straight to circular has a modest effect on the 6-min walk distance. Chest 133:1155–1160

    Article  PubMed  Google Scholar 

  3. Brown CD, Wise RA (2007) Field test of exercise in COPD: the six-minute walk test and the shuttle walk test. COPD 4:217–224

    Article  PubMed  Google Scholar 

  4. Callens E, Graba S, Gillet-Juvin K et al (2009) Measurement of dynamic hyperinflation after a 6-minute walk test in patients with COPD. Chest 136:1466–1472

    Article  PubMed  Google Scholar 

  5. Camarri B, Eastwood PR, Cecin NM et al (2006) Six minute walk distance in healthy subjects aged 55–75 years. Respir Med 100:658–665

    Article  PubMed  Google Scholar 

  6. Cardoso F, Tufanin AT, Colucci M et al (2007) Replacement of the 6-min walk test with maximal oxygen consumption in the BODE index applied to patients with COPD: an equivalence study. Chest 132:477–482

    Article  PubMed  Google Scholar 

  7. Carter R, Holiday DB, Nwasoruba C et al (2003) 6-minute walk work for assessement of functional capacity in patients with COPD. Chest 123:1408–1415

    Article  PubMed  Google Scholar 

  8. Casanova C, Cote C, Marin JM et al (2008) Distance and oxygen desaturation during the 6-min walk test as predictors of long term mortality in patients with COPD. Chest 134:746–752

    Article  PubMed  Google Scholar 

  9. Casanova C, Celli BF, Barria P et al (2010) The 6 minute walk distance in healthy subjects: reference standards from seven countries. Eur Respir J [Epub ahead, doi:10.1183/090331936.00194909]

  10. Casas A, Vilaro J, Rabinovich R et al (2005) Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients. Chest 128:55–61

    Article  PubMed  Google Scholar 

  11. Celli BR, MacNee W (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23:932–946

    Article  PubMed  CAS  Google Scholar 

  12. Celli BR, Cote CG, Marin JM et al (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350:1005–1012

    Article  PubMed  CAS  Google Scholar 

  13. Chetta A, Zanini A, Pisi G et al (2006) Reference values for the 6-min walk test in healthy subjects 20–50 years old. Respir Med 100:1573–1578

    Article  PubMed  Google Scholar 

  14. Cote C, Pino-Plata V, Kasprzyk K et al (2007) The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest 132:1778–1785

    Article  PubMed  Google Scholar 

  15. Cote CG, Casanova C, Marin JM et al (2008) Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J 31:571–578

    Article  PubMed  CAS  Google Scholar 

  16. Demers C, McKelvie RS, Negassa A et al (2001) Reliability, validity, and responsiveness of six-minute walk test in patients with heart failure. Am Heart J 142:698–703

    Article  PubMed  CAS  Google Scholar 

  17. Enright PL, Sherill DL (1998) Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 158:1384–1387

    PubMed  CAS  Google Scholar 

  18. Enright PL, McBurnie MA, Bittner V et al (2003) The 6-min walk test: a quick measure of functional status in elderly adults. Chest 123:387–398

    Article  PubMed  Google Scholar 

  19. Geiger R, Strasak A, Tremel B et al (2007) Six-minute walk test in children and adolescents. J Pediatr 150:395–399

    Article  PubMed  Google Scholar 

  20. Gibbons W, Fruchter N, Sloan S et al (2001) Reference values for a multiple repetition 6-minute-walk test in healthy adults older than 20 years. J Cardiopulm Rehabil 21:87–93

    Article  PubMed  CAS  Google Scholar 

  21. Kroidl RF, Schwarz S, Lehnigk B (2006) Belastungsuntersuchungen in der Pneumologie. Pneumologie 3:149–170

    Article  Google Scholar 

  22. Lama VN, Flaherty KR, Toews GB et al (2003) Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 168:1084–1090

    Article  PubMed  Google Scholar 

  23. Lee W-TN, Peacock AJ, Johnson MK (2010) The role of percent predicted six-minute walk distance in pulmonary arterial hypertension. Eur Respir J [Epub ahead, doi: 10.1183/090331936.00155009]

  24. Olsson LG, Swedberg K, Clark AL et al (2005) Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 26:778–793

    Article  PubMed  CAS  Google Scholar 

  25. Oudiz RJ, Barst RJ, Hansen JE et al (2006) Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension. Am J Cardiol 997:123–126

    Article  Google Scholar 

  26. Palange A, Ward SA, Carlsen K-H et al (2007) Recommendations on the use of exercise testing in clinical practice. Eur Respir J 29:185–209

    Article  PubMed  CAS  Google Scholar 

  27. Pepin V, Brodeur J, Lacasse Y et al (2007) Six-minute walking versus shuttle walking: responsiveness to bronchodilatation in chronic obstructive pulmonary disease. Thorax 62:291–298

    Article  PubMed  Google Scholar 

  28. Poulain M, Durand F, Palomba B et al (2003) 6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest 123:1401–1407

    Article  PubMed  Google Scholar 

  29. Puhan MA, Chandra D, Mosenifar Z et al (2010) The minimal important difference of exercise tests in severe COPD. Eur Respir J [Epub ahead of print, doi: 10.1183/09031936.00063810]

  30. Pulz C, Diniz R, Avez AN et al (2008) Incremental shuttle and six-minute walking tests in the assessment of functional capacity in chronic heart failure. Can J Cardiol 24:131–135

    PubMed  Google Scholar 

  31. Rostagno C, Olivo G, Comeglio M et al (2003) Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation. Eur J Heart Fail 5:247–252

    Article  PubMed  Google Scholar 

  32. Salzman SH (2009) The 6-min walk test: clinical and research role, technique, coding, and reimbursement. Chest 135:1345–1352

    Article  PubMed  Google Scholar 

  33. Shah MR, Hasselblad V, Gheorghiade M et al (2001) Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol 88:987–993

    Article  PubMed  CAS  Google Scholar 

  34. Singh SJ, Jones PW, Revans R, Morgan MDL (2008) Minimum clinically important improvement for the incremental shuttle walking test. Thorax 63:775–777

    Article  PubMed  CAS  Google Scholar 

  35. Solway S, Brooks D, Lacasse Y, Thomas S (2001) A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 119:256–270

    Article  PubMed  CAS  Google Scholar 

  36. Swigris JJ, Swick J, Wamboldt FS (2009) Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis. Chest 136:841–848

    Article  PubMed  Google Scholar 

  37. Troosters T, Gosselink R, Decramer M (1999). Six minute walking distance in healthy elderly subjects. Eur Respir J 14:270–274

    Article  PubMed  CAS  Google Scholar 

  38. Villalba WO, Sampaio-Barros PD, Pereira MC et al (2007) Six-minute-walk test for the evaluation of pulmonary disease severity in scleroderma patients. Chest 131:217–222

    Article  PubMed  Google Scholar 

  39. Weber N, Brandl P, Kohlhäufl M, Häußinger K (2005) Sechs-Minuten-Gehtest mit und ohne Sauerstoff bei Patienten mit COPD: Vergleich von Gehstrecke und Sauerstoffsättigung bei unterschiedlichen Applikationsformen. Pneumologie 60:220–228

    Article  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W. Petermann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Petermann, W., Buschmann, HC. Gehtests. Pneumologe 8, 78–84 (2011). https://doi.org/10.1007/s10405-010-0450-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10405-010-0450-x

Schlüsselwörter

Keywords

Navigation